SLNO logo

SLNO

Soleno Therapeutics Inc.

$52.35
$0.00(0.00%)
45
Overall
55
Value
36
Tech
--
Quality
How is this score calculated?
Market Cap
$2.54B
Volume
17.62M
52W Range
$29.43 - $90.32
Target Price
$104.75

Company Overview

Mkt Cap$2.54BPrice$52.35
Volume17.62MChange+0.00%
P/E Ratio-14.5Open$52.29
Revenue--Prev Close$52.35
Net Income$-175.8M52W Range$29.43 - $90.32
Div YieldN/ATarget$104.75
Overall45Value55
Quality--Technical36

No chart data available

About Soleno Therapeutics Inc.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics (SLNO) and Viridian Therapeutics (VRDN)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Soleno Therapeutics (SLNO) and Viridian Therapeutics (VRDN). Sole...

Christine Brown2 days ago

Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics (SLNO) and Viridian Therapeutics (VRDN)

Christine Brown2 days ago

M&A News: Soleno Therapeutics Stock (SLNO) Surges 28% as Neurocrine Biosciences Lines up $2.5B Deal

David Craik2 days ago

Soleno Therapeutics Faces Investor Lawsuit Over Alleged Safety Disclosures and Stock Drop

Joseph E. Levi7 days ago

SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Drug Safety Risks: Levi & Korsinsky

Joseph E. Levi13 days ago
ABCD
1SymbolPriceChangeVol
2SLNO$52.350%17.62M
3
4
5
6

Get Soleno Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.